Clare Jolly

17PUBLICATIONS
125CO-AUTHORS
Regenerative medicine (incl. stem cells)Proteins and peptidesMajor global burdens of diseaseCharacterisation of biological macromoleculesBiological adaptation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 06, 2026
HIV-1 signalling remodels nuclear pores to licence infection.

|Sep 15, 2025
Human guanylate-binding protein (GBP) 1 inhibits replication of severe acute respiratory syndrome coronavirus 2.

Rubaiyea Farrukee, Francesca Mordant, Charley Mackenzie-Kludas

|Feb 25, 2025
HIV-1 Gag-protease-driven replicative capacity influences T-cell metabolism, cytokine induction, and viral cell-to-cell spread.

Omolara O Baiyegunhi, Kensane Mthembu, Ann-Kathrin Reuschl

|Feb 10, 2025
Macrocycle-based PROTACs selectively degrade cyclophilin A and inhibit HIV-1 and HCV.

Lydia S Newton, Clara Gathmann, Sophie Ridewood

|Jan 16, 2024
Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants.

Ann-Kathrin Reuschl, Lucy G Thorne, Matthew V X Whelan

|Jan 24, 2023
SARS-CoV-2 evolution influences GBP and IFITM sensitivity.

Dejan Mesner, Ann-Kathrin Reuschl, Matthew V X Whelan

Pageof 3

Frequent Collaborators

7 joint publications

Greg J Towers

6 joint publications

Lucy G Thorne

4 joint publications

Ann-Kathrin Reuschl

4 joint publications

Roberta Ragazzini